Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (11): 1120-1124.doi: 10.3969/j.issn.1000-6621.2021.11.004
• Special Topic • Previous Articles Next Articles
Received:
2021-09-06
Online:
2021-11-10
Published:
2021-11-02
Contact:
ZHAO Yan-lin
E-mail:zhaoyl@chinacdc.cn
CHENG Jun, ZHAO Yan-lin. End tuberculosis epidemic by establishing zero tuberculosis community[J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1120-1124. doi: 10.3969/j.issn.1000-6621.2021.11.004
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.11.004
[1] |
Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet, 2014, 383(9934):2057-2064. doi: 10.1016/S0140-6736(13)62639-2.
doi: 10.1016/S0140-6736(13)62639-2 |
[2] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[3] | World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015: Report by the Secretariat. Geneva: World Health Organization, 2014. |
[4] |
Huynh GH, Klein DJ, Chin DP, et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med, 2015, 13:88. doi: 10.1186/s12916-015-0341-4.
doi: 10.1186/s12916-015-0341-4 |
[5] | Maher D, van Gorkom JL, Gondrie PC, et al. Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. Int J Tuberc Lung Dis, 1999, 3(9):762-768. |
[6] |
魏倩, 王仕昌, 曹传兵. 2020年山东省公众结核病防治核心信息知晓率调查结果分析. 中国防痨杂志, 2021, 43(7):741-746. doi: 10.3969/j.issn.1000-6621.2021.07.017.
doi: 10.3969/j.issn.1000-6621.2021.07.017 |
[7] |
吴腾燕, 冯启明, 潘健, 等. 大学新生结核病防治核心知识知晓情况及其影响因素分析. 内科, 2021, 16(3):328-331, 348. doi: 10.16121/j.cnki.cn45-1347/r.2021.03.13.
doi: 10.16121/j.cnki.cn45-1347/r.2021.03.13 |
[8] |
李婕, 王黎霞, 成君, 等. 活动性肺结核患者家庭密切接触者结核病防治核心信息知晓情况调查. 中国防痨杂志, 2015, 37(10):1035-1041. doi: 10.3969/j.issn.1000-6621.2015.10.007.
doi: 10.3969/j.issn.1000-6621.2015.10.007 |
[9] |
许婕, 王朝才, 夏愔愔, 等. 我国高疫情地区主动发现的肺结核患者干预前后接受治疗的意愿及影响因素分析. 中国防痨杂志, 2018, 40(10):1099-1109. doi: 10.3969/j.issn.1000-6621.2018.10.014.
doi: 10.3969/j.issn.1000-6621.2018.10.014 |
[10] | 于兰, 王静, 吕青, 等. 河南开封、重庆永川耐多药肺结核患者健康教育和健康促进服务效果评价. 中国健康教育, 2013, 29(4):365-366. |
[11] | World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. Geneva: World Health Organization, 2013. |
[12] |
Zhang CY, Zhao F, Xia YY, et al. Prevalence and risk factors of active pulmonary tuberculosis among elderly people in China: a population based cross-sectional study. Infect Dis Poverty, 2019, 8(1):7. doi: 10.1186/s40249-019-0515-y.
doi: 10.1186/s40249-019-0515-y |
[13] |
Zhang C, Xia L, Rainey JJ, et al. Findings from a pilot project to assess the feasibility of active tuberculosis case finding among seniors in rural Sichuan Province, China, 2017. PLoS One, 2019, 14(3):e0214761. doi: 10.1371/journal.pone.0214761.
doi: 10.1371/journal.pone.0214761 |
[14] |
许婕, 陈志华, 张灿有, 等. 整合基本公共卫生服务项目加强老年肺结核的主动筛查. 结核病与肺部健康杂志, 2018, 7(3):167-170. doi: 10.3969/j.issn.2095-3755.2018.03.004.
doi: 10.3969/j.issn.2095-3755.2018.03.004 |
[15] |
饶立歆, 肖筱, 陈静, 等. 结核病与艾滋病低流行地区MTB/HIV双重感染患者发现模式的效果评价. 中国防痨杂志, 2021, 43(3):240-247. doi: 10.3969/j.issn.1000-6621.2021.03.009.
doi: 10.3969/j.issn.1000-6621.2021.03.009 |
[16] | 中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02. |
[17] | 王宇. 全球基金结核病控制项目在中国——成就与经验. 北京:人民卫生出版社, 2015: 2. |
[18] |
徐彩红, 张慧, 阮云洲, 等. 我国六省(自治区)全球基金项目地区耐多药肺结核诊疗效果的回顾性分析. 中国防痨杂志, 2018, 40(6):559-563. doi: 10.3969/j.issn.1000-6621.2018.06.003.
doi: 10.3969/j.issn.1000-6621.2018.06.003 |
[19] |
马志涛, 王娜, 吕阳, 等. 上海市宝山区肺结核患者心理状态及其影响因素分析. 中国防痨杂志, 2021, 43(4):378-384. doi: 10.3969/j.issn.1000-6621.2021.04.014.
doi: 10.3969/j.issn.1000-6621.2021.04.014 |
[20] | Results of directly observed short-course chemotherapy in 112, 842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration. in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration. Lancet, 1996, 347(8998):358-362. |
[21] |
Ruan Y, Li L, Xu L, et al. Practical Experiences of Delivering Multidrug-Resistant Tuberculosis Comprehensive Supportive Care Services in China. China CDC Wkly, 2021, 3(26):566-568. doi: 10.46234/ccdcw2021.146.
doi: 10.46234/ccdcw2021.146 |
[22] | 郑晖, 沈小河. 个性化饮食干预对肺结核患者的营养状况及康复情况的影响. 医学食疗与健康, 2021, 19(7):22,115. |
[23] |
李玥璐, 念伟. 结核病患者服药依从性与家庭关怀度的相关性研究. 中华现代护理杂志, 2018, 24(20):2369-2371. doi: 10.3760/cma.j.issn.1674-2907.2018.20.004.
doi: 10.3760/cma.j.issn.1674-2907.2018.20.004 |
[24] |
Getahun H, Matteelli A, Chaisson RE, et al. Latent Mycobacterium tuberculosis Infection. N Engl J Med, 2015, 372(22):2127-2135. doi: 10.1056/NEJMra1405427.
doi: 10.1056/NEJMra1405427 |
[25] |
高磊, 金奇. 关口前移:再谈结核分枝杆菌潜伏感染管理和暴露后干预. 中国防痨杂志, 2021, 43(3):201-203. doi: 10.3969/j.issn.1000-6621.2021.03.002.
doi: 10.3969/j.issn.1000-6621.2021.03.002 |
[26] | World Health Organization. WHO policy on TB infection control in health-care facilities, congregate settings and households. Geneva: World Health Organization, 2009. |
[27] |
Jiang Q, Liu Q, Ji L, et al. Citywide Transmission of Multidrug-resistant Tuberculosis Under China’s Rapid Urbanization: A Retrospective Population-based Genomic Spatial Epidemiological Study. Clin Infect Dis, 2020, 71(1):142-151. doi: 10.1093/cid/ciz790.
doi: 10.1093/cid/ciz790 |
[28] |
Yang C, Gao Q. Recent transmission of Mycobacterium tuberculosis in China: the implication of molecular epidemiology for tuberculosis control. Front Med, 2018, 12(1):76-83. doi: 10.1007/s11684-017-0609-5.
doi: 10.1007/s11684-017-0609-5 |
[29] |
Wu P, Lau EH, Cowling BJ, et al. The transmission dynamics of tuberculosis in a recently developed Chinese city. PLoS One, 2010, 5(5):e10468. doi: 10.1371/journal.pone.0010468.
doi: 10.1371/journal.pone.0010468 |
[30] |
Seto J, Wada T, Suzuki Y, et al. Mycobacterium tuberculosis Transmission among Elderly Persons, Yamagata Prefecture, Japan, 2009-2015. Emerg Infect Dis, 2017, 23(3):448-455. doi: 10.3201/eid2303.161571.
doi: 10.3201/eid2303.161571 |
[31] |
王静, 夏愔愔, 李涛, 等. 不同地区和年龄组人群接受结核病防治健康教育途径的分析. 中国防痨杂志, 2019, 41(6):687-694. doi: 10.3969/j.issn.1000-6621.2019.06.017.
doi: 10.3969/j.issn.1000-6621.2019.06.017 |
[32] |
王前, 何金戈, 李玉红, 等. 人工智能自动阅片技术用于HIV/AIDS人群结核病主动筛查效果的研究. 中国防痨杂志, 2021, 43(6):557-561. doi: 10.3969/j.issn.1000-6621.2021.06.007.
doi: 10.3969/j.issn.1000-6621.2021.06.007 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||